Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma.

In brief

This case series reports successful medical management of juvenile nasopharyngeal angiofibroma using sirolimus, an mTOR inhibitor, as an alternative to traditional surgical and radiation approaches. Three patients demonstrated clinical and radiographic improvement with sirolimus therapy, suggesting a potential role for targeted medical treatment in this locally aggressive vascular tumor.

Written by the GCMD Library team from the article.